Bicalutamide Activated Oncolytic Adenovirus for the Adjuvant Therapy of High Risk Prostate Cancer

Conditionally replicating adenoviruses (CRAds) utilize tissue specific promoters to control the expression of the early genes, E1A and E1B, to preferentially replicate and lyse tumor cells (oncolysis). Previous CRAds used in prostate cancer gene therapy require androgens to activate prostate specifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, Tamara Jane, Hoti, Naser Uddin, Liu, Chunyan, Chowdhury, Wasim H., Li, Ying, Zhang, Yonggang, Lupold, Shawn E., DeWeese, Theodore, Rodriguez, Ronald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3732197/
https://www.ncbi.nlm.nih.gov/pubmed/23764901
http://dx.doi.org/10.1038/cgt.2013.34

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3732197/
https://www.ncbi.nlm.nih.gov/pubmed/23764901
http://dx.doi.org/10.1038/cgt.2013.34

Ejemplares similares